Terms: = Pancreatic cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
1909 results:
1. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
[TBL] [Abstract] [Full Text] [Related]
2. Pancreas Β-Cells in Type 1 and Type 2 Diabetes: Cell Death, Oxidative Stress and Immune Regulation. Recently Appearing Changes in Diabetes Consequences.
Novoselova EG; Lunin SM; Khrenov MO; Glushkova OV; Novoselova TV; Parfenyuk SB
Cell Physiol Biochem; 2024 Apr; 58(2):144-155. PubMed ID: 38639210
[TBL] [Abstract] [Full Text] [Related]
3. Unlocking the Role of Age-Related Changes to Fibroblasts in pancreatic cancer.
Isaacson A; Barki D; Scherz-Shouval R
Cancer Res; 2024 Apr; 84(8):1185-1187. PubMed ID: 38616657
[TBL] [Abstract] [Full Text] [Related]
4. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer.
Luo Z; Chen Y; Chen B; Zhao Z; Wu R; Ren J
BMC Med Genomics; 2024 Apr; 17(1):82. PubMed ID: 38581025
[TBL] [Abstract] [Full Text] [Related]
5. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis.
Wang Y; Kong Y; Yang Q; Zhong C; Zhou D
Eur J Med Res; 2024 Apr; 29(1):221. PubMed ID: 38581008
[TBL] [Abstract] [Full Text] [Related]
6. Highly sensitive serum volatolomic biomarkers for pancreatic cancer diagnosis.
Martínez-Moral MP; Tena MT; Martín-Carnicero A; Martínez A
Clin Chim Acta; 2024 Apr; 557():117895. PubMed ID: 38561063
[TBL] [Abstract] [Full Text] [Related]
7. The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy.
Lu W; Wu G; Miao X; Ma J; Wang Y; Xu H; Shentu D; Xue S; Xia Q; Wang Y; Wang L
Cancer Immunol Immunother; 2024 Mar; 73(5):87. PubMed ID: 38554161
[TBL] [Abstract] [Full Text] [Related]
8. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
[TBL] [Abstract] [Full Text] [Related]
9. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer's disease through machine learning algorithms.
Jiang L; Wang Q; Jiang Y; Peng D; Zong K; Li S; Xie W; Zhang C; Li K; Wu Z; Huang Z
Clin Chim Acta; 2024 Apr; 557():117892. PubMed ID: 38537674
[TBL] [Abstract] [Full Text] [Related]
10. Design and evaluation of a multiepitope vaccine for pancreatic cancer using immune-dominant epitopes derived from the signature proteome in expression datasets.
Banesh S; Patil N; Chethireddy VR; Bhukmaria A; Saudagar P
Med Oncol; 2024 Mar; 41(5):90. PubMed ID: 38522058
[TBL] [Abstract] [Full Text] [Related]
11. A pyrimidine metabolism-related signature for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma by integrating analyses.
Zhang S; Qin O; Wu S; Xu H; Huang W; Hailiang S
Aging (Albany NY); 2024 Mar; 16(6):5545-5566. PubMed ID: 38517376
[TBL] [Abstract] [Full Text] [Related]
12. Combining bulk and scRNA-seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC.
Zhu S; Cheng Q; Zou M; Li C; Tang Y; Xia L; Jiang Y; Gong Z; Tang Z; Tang Y; Luo H; Peng N; Wang X; Dong X
J Cell Mol Med; 2024 Apr; 28(7):e18266. PubMed ID: 38501838
[TBL] [Abstract] [Full Text] [Related]
13. Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-cancer Clinicogenomic Data set.
Kehl KL; Lavery JA; Brown S; Fuchs H; Riely G; Schrag D; Newcomb A; Nichols C; Micheel CM; Bedard PL; Sweeney SM; Fiandalo M; Panageas KS;
JCO Precis Oncol; 2024 Mar; 8():e2300489. PubMed ID: 38484212
[TBL] [Abstract] [Full Text] [Related]
14. Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progression.
Zhong Z; Yang K; Li Y; Zhou S; Yao H; Zhao Y; Huang Y; Zou J; Li Y; Jiajia Li ; Lian G; Huang K; Chen S
Cancer Lett; 2024 Apr; 588():216784. PubMed ID: 38458594
[TBL] [Abstract] [Full Text] [Related]
15. Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter study.
Man Q; Pang H; Liang Y; Chang S; Wang J; Gao S
Medicine (Baltimore); 2024 Mar; 103(10):e37440. PubMed ID: 38457597
[TBL] [Abstract] [Full Text] [Related]
16. Screening of genes characteristic of pancreatic cancer by LASSO regression combined with support vector machine and recursive feature elimination, and immune correlation analysis.
Zeng L; Chen Z
J Int Med Res; 2024 Mar; 52(3):3000605241233160. PubMed ID: 38456653
[TBL] [Abstract] [Full Text] [Related]
17. Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.
Li X; Fan Y; Tong J; Lou M
Front Endocrinol (Lausanne); 2024; 15():1264952. PubMed ID: 38449852
[TBL] [Abstract] [Full Text] [Related]
18. Exploration of YBX1 role in the prognostic value and immune characteristics by single-cell and bulk sequencing analysis for liver hepatocellular carcinoma.
Zhang Q; Zhu B; Yang H; Li F; Qu Y; Lu L; Zhang Q
J Gene Med; 2024 Mar; 26(3):e3680. PubMed ID: 38448368
[TBL] [Abstract] [Full Text] [Related]
19. Construction of individualised care programmes for patients with pancreatic cancer with postoperative weight-loss control based on the Delphi method: a cross-sectional study in China.
Chen L; Huang Z; Tian Q; Zha Q; Zhang S; Chen Z; Dong Z; Zhou Y; Zhang M; Wei X
J Health Popul Nutr; 2024 Mar; 43(1):36. PubMed ID: 38429793
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201).
Imai H; Sakamoto Y; Takahashi S; Shibata H; Sato A; Otsuka K; Amagai K; Takahashi M; Yamaguchi T; Ishioka C
BMC Cancer; 2024 Feb; 24(1):262. PubMed ID: 38402399
[TBL] [Abstract] [Full Text] [Related]
[Next]
